# Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

> **NCT02682667** · — · RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 500 (estimated)

## Conditions studied

- Multiple Myeloma
- Lymphoma, Non-Hodgkin
- Leukemia-Lymphoma, Adult T-Cell
- Hodgkin Disease
- Non-Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02682667
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-04-11
- **Primary completion:** 2030-12-01
- **Final completion:** 2032-12-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682667, "Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02682667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*